Tradestie Institutional Equity Comparison Engine

DCTH vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DCTH
DCTH N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin 5.2% vs -125.2% ยท YoY +70.7% vs -8.3%
Momentum & Technical Winner DCTH
1Y +130.6% vs -46.9% ยท 52W Pos 82% vs 4%
Options & Structure Winner DCTH
BREAKOUT (43rd %ile IV) vs UNCLASSIFIED (N/A IV)
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.85
-3.41% 1D
Market Cap $743.8M
1M Return +40.98%
1Y Return +130.55%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCTH +130.55% BMRA -46.86% Spread: +177.41 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DCTH Revenue BMRA Revenue DCTH Op. Margin BMRA Op. Margin Margin Edge
FY2019 N/A $10M N/A -46.4% BMRA
FY2020 N/A $10M N/A -41.0% BMRA
FY2021 $0M $10M -690.0% -104.2% BMRA
FY2022 $0M $20M -1245.1% -24.0% BMRA
FY2023 $0M $10M -1849.0% -135.3% BMRA
FY2024 $40M $10M -33.4% -117.6% DCTH
FY2025 $90M $10M 0.8% -96.7% DCTH
FY2026 N/A $0M N/A -119.5% BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCTH (7) vs BMRA (2)
Institutional Metric DCTH BMRA Criterion Row Winner
Market Capitalization Scale $743.8M $6.0M Larger Scale DCTH
Trailing P/E Ratio Valuation 133.6x N/M Lower Multiple DCTH
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +70.7% -8.3% Higher Growth DCTH
Operating Margin (TTM) Profitability 5.2% -125.2% Higher Margin DCTH
Net Profit Margin Profitability 6.0% -115.5% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency 5.4% -113.8% Higher ROE DCTH
52-Week Range Position Momentum 82% ($8โ€“$23) 4% ($1โ€“$3) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 1.65ฮฒ ยท 132% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCTH vs BMRA Buy Guide
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCTH nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.